Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece
- None.
- None.
This year's meeting will focus on the latest advances and clinical applications of liquid biopsy, with presentations on CTCs, circulating tumor DNA, circulating miRNAs and more. The Company's participation will include a poster sharing research into potential use of its Co-Primers™ technology in liquid biopsy applications, as well as a brief presentation about the upcoming Co-Dx PCR Home™ platform and its potential to transform infectious disease diagnosis worldwide.
More information about the conference can be found here. Parties interested in learning more about the Company's products or research into liquid biopsy are invited to visit Booth #9.
The Co-Dx PCR Home platform is subject to FDA review and is not available for sale.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-participate-in-6th-actc-conference-in-skiathos-greece-301935708.html
SOURCE Co-Diagnostics